Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...

This study presents a comprehensive benchmarking of human-derived transcription activation domains (hTADs) for use in CRISPR-based artificial ...

CRISPR screens often mislead cancer research because bacterial Cas9 components trigger immune reactions in mice. ETH Zurich ...

The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer ...

A breakthrough study has just supercharged Fusarium venenatum (the fungus used in mycoprotein products like Quorn), turning ...

The gene editing solution for Sickle Cell Disease, a chronic, single-gene disorder that causes a debilitating systemic syndrome characterised by chronic anaemia ...

CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing ...

As tech titans back startups looking to create genetically modified babies, Claudia Cockerell asks: is it about stopping disease, or something darker?

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Chronic diseases once meant a lifetime of management. But a new generation of cell and gene therapies is challenging that paradigm. Markets are responding. The global cell and gene therapy market is ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...

Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a ...